TELA Bio director Joseph Capper files insider statement

TELA Bio, Inc. director Joseph H. Capper has filed an initial statement of beneficial ownership as an insider.

Rhea-AI Filing Summary

TELA Bio, Inc. director Joseph H. Capper has filed an initial statement of beneficial ownership as an insider. This Form 3 does not report any insider purchases, sales, option exercises, gifts, or other equity transactions, reflecting only his new status as a reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Joseph H. Capper Form 3 for TELA (TELA) show?

The Form 3 shows that Joseph H. Capper became a director and is now an insider reporting person for TELA Bio, Inc. It is an initial beneficial ownership statement and does not report any equity transactions in TELA shares or derivatives.

Did Joseph H. Capper buy or sell TELA Bio (TELA) shares in this Form 3?

No, this Form 3 does not report any purchases or sales of TELA Bio shares by Joseph H. Capper. The transaction summary shows zero buys, zero sells, and no option exercises or other dispositions during the period covered by this filing.

What insider activity counts are disclosed for TELA Bio (TELA) in this Form 3?

The filing shows zero buy transactions, zero sell transactions, zero option exercises, zero gifts, and zero tax-withholding or restructuring events. It is purely an initial registration of Joseph H. Capper’s status as a director and reporting person at TELA Bio.

Does the TELA (TELA) Form 3 include any derivative positions or options?

No derivative positions or options are listed in this Form 3 for TELA Bio. The derivative transaction count is zero and the derivative summary section is empty, indicating no options, warrants, or similar securities are reported in this initial statement.

What is the net buy/sell direction in Joseph H. Capper’s TELA Bio Form 3?

The net buy/sell direction is reported as neutral because there are no transactions in this Form 3. Net buy/sell shares are zero, with no buys, sells, or other equity movements recorded for Joseph H. Capper in the disclosed summary data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 06:10 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Capper Joseph H

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Megan Smeykal, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)